Citation: | MA Aiwen, XU Jiyang, CHEN Jun, XU Min. Values of N-terminal B-type natriuretic peptide and cardiac troponin I in evaluating disease condition of patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 16-19. DOI: 10.7619/jcmp.202007005 |
Nishikimi T, Minamino N, Ikeda M, et al. Diversity of molecular forms of plasma brain natriuretic peptide in heart failure different proBNP-108 to BNP-32 ratios in atrial and ventricular overload[J]. Heart, 2010, 96: 432-439.
|
乔中会, 李俊萍. 慢性阻塞性肺疾病急性加重期患者死亡原因探讨[J]. 临床肺科杂志, 2012, 17(7): 1309-1310.
|
Han M K, Martinez F J. Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease[J]. Proc Am Thorac Soc, 2011, 8(4): 356-362.
|
Criner G J, Bourbeau J, Diekemper R L, et al. Prevention of acute exacerbations of COPD: American college of chest physicians and Canadian thoracic society guideline[J]. Chest, 2015, 147(4): 894-942.
|
任立新, 周建军, 裴金宝, 等. COPD合并肺心病患者血NT-proBNP水平变化研究[J]. 临床肺科杂志, 2014, 19(7): 1217-1219.
|
张敏. 应用多普勒超声心动图估测肺动脉高压的分析[J]. 华夏医学, 2006, 19(6): 1104-1105.
|
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 肺动脉高压筛查诊断与治疗专家共识[J]. 中华心血管病杂志, 2007, 35(11): 979-987.
|
Pavasini R, Tavazzi G, Biscaglia S, et al. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis[J]. Chron Respir Dis, 2017, 14(2): 117-126.
|
Fisher C. N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure[J]. Heart, 2003, 89(8): 879-881.
|
Minai O A, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective[J]. Chest, 2010, 137(Suppl 6): 39S-51S.
|
王娜娜, 孟自力, 陈亮, 等. 慢性阻塞性肺疾病并发肺动脉高压血清标志物研究[J]. 临床肺科杂志, 2016, 21(6): 1051-1055.
|
Marcun R, Sustic A, Brguljan P M, et al. Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease[J]. Int J Cardiol, 2012, 161(3): 156-159.
|
Abroug F, Ouanes-Besbes L, Nciri N, et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers[J]. Am J Respir Crit Care Med, 2006, 174(9): 990-996.
|
徐莉, 徐晓. 血清25(OH)D、Lp(a)和cTnI水平对慢性阻塞性肺疾病急性加重患者合并冠心病患者早期诊断的临床研究[J]. 临床肺科杂志, 2020, 25(1): 3-7.
|
宋祝, 王蒙, 徐昕烨, 等. COPD与冠脉病变严重程度的相关性分析[J]. 国际呼吸杂志, 2017(12): 921-925.
|
Fimognari F L, Scarlata S, Conte M E, et al. Mechanisms of atherothrombosis in chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2008, 3(1): 89-96.
|